Results 181 to 190 of about 50,426 (246)
Some of the next articles are maybe not open access.
Alopecia Totalis and Topical Mustine
Archives of Dermatology, 1993To the Editor.— Seven patients with long-standing alopecia totalis (duration >5 years) had not responded to therapies including topical steroids, intralesional steroids, and topical dinitrochlorobenzine plus diphencyprone. Because of a lymphocytic effect of nitrogen mustard 1 and the involvement of lymphocytes in the pathogenesis of alopecia areata, 2
P V, Harrison, J, Latona, M, Jovanovic
openaire +2 more sources
PRP for Immune Mediated Alopecias (Alopecia Areata, Alopecia Totalis)
2021Alopecia areata (AA) is a common cause of non-cicatricial hair loss with a sudden, unpredictable, and recurrent course that is associated with significant psychosocial burden. Current treatment options, such as topical and intralesional corticosteroids, systemic immunosuppression, topical immunotherapy, and Janus Kinase Inhibitors (JAK inhibitors ...
Nina Semsarzadeh, Jeffrey S. Dover
openaire +1 more source
Overcoming emotional struggles and alopecia totalis: homeopathic healing at Dr. Batra’s
International Journal of Homoeopathic SciencesAlopecia totalis is an autoimmune disorder characterized by the complete loss of hair on the scalp, often resulting from an overactive immune system attacking hair follicles.
Alopecia totalis +1 more
semanticscholar +1 more source
Journal of Cutaneous Medicine and Surgery
BACKGROUND Severe alopecia areata (AA), including alopecia totalis (AT) and alopecia universalis (AU), can cause diffuse thinning or complete loss of scalp and body hair.
Jundong Huang +4 more
semanticscholar +1 more source
BACKGROUND Severe alopecia areata (AA), including alopecia totalis (AT) and alopecia universalis (AU), can cause diffuse thinning or complete loss of scalp and body hair.
Jundong Huang +4 more
semanticscholar +1 more source
Dermatology, 2021
Background: Alopecia areata (AA) is an autoimmune disease typified by nonscarring hair loss with a variable clinical course. Although there is an increased understanding of AA pathogenesis and progress in its treatments, the outcome of AA patients ...
Tao Zhang, Yingli Nie
semanticscholar +1 more source
Background: Alopecia areata (AA) is an autoimmune disease typified by nonscarring hair loss with a variable clinical course. Although there is an increased understanding of AA pathogenesis and progress in its treatments, the outcome of AA patients ...
Tao Zhang, Yingli Nie
semanticscholar +1 more source
Exploring the Use of Topical Tofacitinib in Pediatric Alopecia Totalis
International Journal of TrichologyAlopecia totalis (AT) is an autoimmune condition and severe form of alopecia areata characterized by complete scalp hair loss, often posing treatment challenges, especially in pediatric patients.
Sahil Sardana
semanticscholar +1 more source
Dermatologic Therapy, 2022
Bimatoprost is a synthetic prostaglandin structural analogue used among other indications to increase eyelash growth. The aim of this prospective, open‐label study was to evaluate the safety and efficacy of topical bimatoprost in the treatment of eyelash
J. Ricar +3 more
semanticscholar +1 more source
Bimatoprost is a synthetic prostaglandin structural analogue used among other indications to increase eyelash growth. The aim of this prospective, open‐label study was to evaluate the safety and efficacy of topical bimatoprost in the treatment of eyelash
J. Ricar +3 more
semanticscholar +1 more source
Review of treatment for alopecia totalis and alopecia universalis
International Journal of Dermatology, 2017AbstractAlopecia areata (AA) is an autoimmune disease directed at the hair follicle. Although usually limited to patchy hair loss over the scalp (focalis), AA can present as total loss of scalp hair (totalis; AT) or as total loss of both scalp and body hair (universalis; AU).
Sama, Kassira +3 more
openaire +2 more sources
Pediatric dermatology, 2022
Alopecia totalis (AT) is a cosmetically debilitating chronic disease characterized by non‐scarring hair loss of the entire scalp. The clinical course of AT is highly unpredictable, and effective durable treatment options are limited.
Ariane L'Ecuyer +3 more
semanticscholar +1 more source
Alopecia totalis (AT) is a cosmetically debilitating chronic disease characterized by non‐scarring hair loss of the entire scalp. The clinical course of AT is highly unpredictable, and effective durable treatment options are limited.
Ariane L'Ecuyer +3 more
semanticscholar +1 more source
Acta dermatovenerologica Alpina, Pannonica, et Adriatica, 2006
From a group of 1,189 AA patients seen in our dermatology unit, thirteen (3 males, 10 females) experienced hair shedding that started profusely and diffusely over the entire scalp. They were under observation for about 5 years, histopathology and trichograms being performed in all instances. The mean age of the patients was 26.7 years. It took only 2.3
Choi, Hye-Ja, Ihm, Chull-Wan
openaire +2 more sources
From a group of 1,189 AA patients seen in our dermatology unit, thirteen (3 males, 10 females) experienced hair shedding that started profusely and diffusely over the entire scalp. They were under observation for about 5 years, histopathology and trichograms being performed in all instances. The mean age of the patients was 26.7 years. It took only 2.3
Choi, Hye-Ja, Ihm, Chull-Wan
openaire +2 more sources